These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32569411)

  • 1. Universal molecular Clostridioides difficile screening and overtreatment in solid organ transplant recipients.
    McCort MN; Oehler C; Enriquez M; Landon E; Nguyen CT; Pettit NN; Ridgway J; Pisano J
    Transpl Infect Dis; 2020 Oct; 22(5):e13375. PubMed ID: 32569411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxigenic
    Keegan J; Buchan BW; Ledeboer NA; Zhou Z; Hong JC; Graham MB; Munoz-Price LS
    Infect Control Hosp Epidemiol; 2021 Mar; 42(3):287-291. PubMed ID: 32933595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients.
    Schluger A; Rosenblatt R; Knotts R; Verna EC; Pereira MR
    Transpl Infect Dis; 2019 Dec; 21(6):e13184. PubMed ID: 31571380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of C difficile infection in solid-organ transplant recipients: The National Inpatient Sample (NIS) 2015-2016.
    Mahatanan R; Tantisattamo E; Charoenpong P; Ferrey A
    Transpl Infect Dis; 2021 Feb; 23(1):e13459. PubMed ID: 32894617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Clostridioides Difficile Diarrhea In Solid Organ Transplantation Recipients.
    Ortiz-Balbuena J; Royuela A; Calderón-Parra J; Martínez-Ruiz R; Asensio-Vegas Á; Múñez E; Valencia-Alijo Á; Gutiérrez-Rojas Á; Ussetti P; Cuervas-Mons V; Segovia-Cubero J; Portolés-Pérez J; Ramos-Martínez A
    Transplant Proc; 2021 Dec; 53(10):2826-2832. PubMed ID: 34772488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.
    Blumberg EA; Collins G; Young JH; Nguyen MH; Michonneau D; Temesgen Z; Origȕen J; Barcan L; Obeid KM; Belloso WH; Gras J; Corbelli GM; Neaton JD; Lundgren J; Snydman DR; Molina JM;
    Transpl Infect Dis; 2022 Feb; 24(1):e13770. PubMed ID: 34821423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients.
    Obeid KM; Sapkota S; Cao Q; Richmond S; Watson AP; Karadag FK; Young JH; Pruett T; Weisdorf DJ; Ustun C
    Transpl Infect Dis; 2022 Feb; 24(1):e13720. PubMed ID: 34455662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study.
    Nguyen CT; Li J; Anders S; Garcia-Diaz J; Staffeld-Coit C; Hand J
    Transpl Infect Dis; 2018 Jun; 20(3):e12867. PubMed ID: 29512244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children.
    Ochfeld E; Balmert LC; Patel SJ; Muller WJ; Kociolek LK
    Transpl Infect Dis; 2019 Oct; 21(5):e13149. PubMed ID: 31332916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Microbiota Transplant in Pediatric Solid Organ Transplant Recipients.
    Rodig NM; Weatherly M; Kaplan AL; Ballal SA; Elisofon SA; Daly KP; Kahn SA
    Transplantation; 2023 Sep; 107(9):2073-2077. PubMed ID: 37211643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic Stewardship and Inpatient Clostridioides difficile Testing in Solid Organ Transplant Recipients: The Need for Multilevel Checks and Balances.
    Kueht M; Kharsa A; Mujtaba M; Kulkarni R; Britt R; Lea AS; Hafiz G; Fair J; Reynoso D
    Transplant Proc; 2022 Apr; 54(3):605-609. PubMed ID: 35249732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is diagnostic stewardship possible in solid organ transplantation?
    Husson J; Bork JT; Morgan D; Baddley JW
    Transpl Infect Dis; 2022 Oct; 24(5):e13899. PubMed ID: 36254510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.
    Hosseini-Moghaddam SM; Luo B; Bota SE; Husain S; Silverman MS; Daneman N; Brown KA; Paterson JM
    JAMA Netw Open; 2021 Dec; 4(12):e2141089. PubMed ID: 34964852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study.
    Korayem GB; Eljaaly K; Matthias KR; Zangeneh TT
    Transplant Proc; 2018; 50(1):137-141. PubMed ID: 29407296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial stewardship in solid organ transplant recipients: Current challenges and proposed metrics.
    Raglow Z; Advani SD; Aitken SL; Patel PK
    Transpl Infect Dis; 2022 Oct; 24(5):e13883. PubMed ID: 36254525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice.
    Mullane KM; Dubberke ER;
    Clin Transplant; 2019 Sep; 33(9):e13564. PubMed ID: 31002420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter study to define the epidemiology and outcomes of Clostridioides difficile infection in pediatric hematopoietic cell and solid organ transplant recipients.
    Mayer EF; Maron G; Dallas RH; Ferrolino J; Tang L; Sun Y; Danziger-Isakov L; Paulsen GC; Fisher BT; Vora SB; Englund J; Steinbach WJ; Michaels M; Green M; Yeganeh N; Gibson JE; Dominguez SR; Nicholson MR; Dulek DE; Ardura MI; Rajan S; Gonzalez BE; Beneri C; Herold BC
    Am J Transplant; 2020 Aug; 20(8):2133-2142. PubMed ID: 32064754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a Clostridioides Difficile Testing Computerized Clinical Decision Support Tool on an Adult Stem Cell Transplantation and Hematologic Malignancies Unit.
    Nix CD; Messer WB; Hale ML; Lewis JS; Strasfeld LM
    Transplant Cell Ther; 2021 Jan; 27(1):94.e1-94.e5. PubMed ID: 33045386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Bezlotoxumab for Prevention of Recurrent
    Johnson TM; Howard AH; Miller MA; Allen LL; Huang M; Molina KC; Bajrovic V
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab294. PubMed ID: 34262988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral vancomycin for Clostridioides difficile prophylaxis in allogenic hematopoietic cell transplant.
    Altemeier OJ; Konrardy KT
    Transpl Infect Dis; 2022 Apr; 24(2):e13790. PubMed ID: 35014136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.